Reply to the letter entitled “Inflammation in Heart Failure with Preserved Ejection Fraction: A Bystander or A Participant?” by Zhong M and Yan X
Autores da FMUP
Participantes de fora da FMUP
- Zannad F.
- Solomon S.D.
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1874-1754, 0167-5273
- Tipo:
- Letter
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
International Journal of Cardiology Elsevier Ireland Ltd
Documentos
- Não há documentos
Filiações
Keywords
- Heart Failure; Humans; Inflammation; Stroke Volume; C reactive protein; cytokine; glucagon like peptide 1; interleukin 6; sodium glucose cotransporter 2 inhibitor; cardiovascular mortality; disease association; disease course; heart failure; heart failure with preserved ejection fraction; human; inflammation; letter; Letter; obesity; heart stroke volume; pathophysiology; physiology
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Citar a publicação
Ferreira JP,Zannad F,Solomon SD. Reply to the letter entitled “Inflammation in Heart Failure with Preserved Ejection Fraction: A Bystander or A Participant?” by Zhong M and Yan X. Int. J. Cardiol. 2024. 411132278. IF:3,500. (2).